Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
First Claim
Patent Images
1. A method of reducing fused in sarcoma/translocated in sarcoma (FUS/TLS)- or TAR-DNA-binding protein 43 (TDP-43)-mediated neuronal cytotoxicity, the method comprising:
- providing to a neuronal cell a composition comprising a UPF1 polypeptide or a nucleic acid encoding a UPF1 polypeptide, thereby reducing the FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in the neuronal cell;
wherein the UPF1 polypeptide comprises the amino acid sequence of SEQ ID NO;
2.
1 Assignment
0 Petitions
Accused Products
Abstract
Nonsense-mediated mRNA decay (NMD) polypeptides, nucleic acids encoding NMD polypeptides, and methods of using such polypeptides and nucleic acids in the treatment of ALS and in screening for agents for the treatment of ALS are described.
12 Citations
7 Claims
-
1. A method of reducing fused in sarcoma/translocated in sarcoma (FUS/TLS)- or TAR-DNA-binding protein 43 (TDP-43)-mediated neuronal cytotoxicity, the method comprising:
-
providing to a neuronal cell a composition comprising a UPF1 polypeptide or a nucleic acid encoding a UPF1 polypeptide, thereby reducing the FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in the neuronal cell; wherein the UPF1 polypeptide comprises the amino acid sequence of SEQ ID NO;
2. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification